NCT02791438View on ClinicalTrials.gov

A Phase 3 Long-term Study of TAK-536 in Pediatric Patients 6 to Less Than 16 Years With Hypertension

PHASE3CompletedINTERVENTIONAL

Enrollment

27

Participants

Timeline

Start Date

August 18, 2016

Primary Completion Date

June 4, 2019

Study Completion Date

June 4, 2019

Conditions

Pediatric Hypertension

Interventions

DRUG

Azilsartan

Azilsartan granules and tablets

DRUG

Placebo

Placebo-matching azilsartan granules and tablets

Trial Locations (30)

Unknown

Nagakute

Nagoya

Ōbu

Sapporo

Kobe

Kanazawa

Yokohama

Nankoku

Sendai

Shimajiri-gun

Izumi

Ōsaka-sayama

Ōtsu

Shimotsuke

Fuchū

Nerima-ku

Ōta-ku

Setagaya-ku

Shinjuku-ku

Akita

Chiba

Fukuoka

Fukushima

Hiroshima

Niigata

Okayama

Osaka

Saitama

Shizuoka

Wakayama

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Takeda

INDUSTRY